Cartesian Therapeutics, Inc. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
Cartesian Therapeutics, Inc. (RNAC) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One of $11.48 million as of 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Notes › Investments › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue · last filed 2019-08-08
- 2019-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $11.48M.
- 2019-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $16.24M.
- 2018-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $0.00.
- 2018-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $5.99M.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One |
|---|---|
| 2019-06-30 | $11.48M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $16.24M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $0.00 10-Q · filed 2019-08-08 |
| 2018-06-30 | $5.99M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $24.84M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $25.94M 10-K · filed 2019-03-15 |
| 2017-09-30 | $32.24M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $30.02M 10-Q · filed 2017-08-11 |
| 2017-03-31 | $41.19M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $24.79M 10-K · filed 2018-03-15 |
| 2016-09-30 | $19.79M 10-Q · filed 2016-11-10 |
| 2015-12-31 | $3.52M 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |